Soleus Capital Management, L.P. Illumina, Inc. Transaction History

Soleus Capital Management, L.P.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$92.79 - $142.53 $491,787 - $755,409	5,300 New	5,300 $737,000
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $8.42 Million - $10.7 Million	45,900 New	45,900 $8.61 Million
Q4 2022 Feb 14, 2023	SELL	$187.24 - $242.74 $23.8 Million - $30.9 Million	-127,338 Reduced 84.0%	24,262 $4.91 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $26.9 Million - $34.5 Million	151,600 New	151,600 $28.9 Million
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $11.3 Million - $22.9 Million	-62,300 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$303.87 - $423.8 $18.9 Million - $26.4 Million	62,300 New	62,300 $21.8 Million

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.7B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Soleus Capital Management, L.P. with notifications on news.